Cargando…

Apixaban as a Rare Cause of Leukocytoclastic Vasculitis

Apixaban is a rare cause of leukocytoclastic vasculitis (LCV). To our knowledge, there is only one other reported case due to apixaban in the literature. We present a case of apixaban-induced leukocytoclastic vasculitis in a 95-year-old male. He had been started on apixaban 12 days prior to presenta...

Descripción completa

Detalles Bibliográficos
Autores principales: Spears, Jenna, Chetrit, David Alexandre, Manthey, Sina, Lee, Christopher, Al-Saiegh, Yousif
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063214/
https://www.ncbi.nlm.nih.gov/pubmed/32181045
http://dx.doi.org/10.1155/2020/7234069
_version_ 1783504672112246784
author Spears, Jenna
Chetrit, David Alexandre
Manthey, Sina
Lee, Christopher
Al-Saiegh, Yousif
author_facet Spears, Jenna
Chetrit, David Alexandre
Manthey, Sina
Lee, Christopher
Al-Saiegh, Yousif
author_sort Spears, Jenna
collection PubMed
description Apixaban is a rare cause of leukocytoclastic vasculitis (LCV). To our knowledge, there is only one other reported case due to apixaban in the literature. We present a case of apixaban-induced leukocytoclastic vasculitis in a 95-year-old male. He had been started on apixaban 12 days prior to presentation and developed worsening palpable purpura of his lower extremities. Possible etiologies of this new rash were excluded, with biopsy showing extensive purpura with superficial perivascular neutrophilic infiltrate and leukocytoclasis. Apixaban was discontinued, and the patient was started on a slow prednisone taper with subsequent resolution of his rash.
format Online
Article
Text
id pubmed-7063214
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-70632142020-03-16 Apixaban as a Rare Cause of Leukocytoclastic Vasculitis Spears, Jenna Chetrit, David Alexandre Manthey, Sina Lee, Christopher Al-Saiegh, Yousif Case Rep Rheumatol Case Report Apixaban is a rare cause of leukocytoclastic vasculitis (LCV). To our knowledge, there is only one other reported case due to apixaban in the literature. We present a case of apixaban-induced leukocytoclastic vasculitis in a 95-year-old male. He had been started on apixaban 12 days prior to presentation and developed worsening palpable purpura of his lower extremities. Possible etiologies of this new rash were excluded, with biopsy showing extensive purpura with superficial perivascular neutrophilic infiltrate and leukocytoclasis. Apixaban was discontinued, and the patient was started on a slow prednisone taper with subsequent resolution of his rash. Hindawi 2020-02-26 /pmc/articles/PMC7063214/ /pubmed/32181045 http://dx.doi.org/10.1155/2020/7234069 Text en Copyright © 2020 Jenna Spears et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Spears, Jenna
Chetrit, David Alexandre
Manthey, Sina
Lee, Christopher
Al-Saiegh, Yousif
Apixaban as a Rare Cause of Leukocytoclastic Vasculitis
title Apixaban as a Rare Cause of Leukocytoclastic Vasculitis
title_full Apixaban as a Rare Cause of Leukocytoclastic Vasculitis
title_fullStr Apixaban as a Rare Cause of Leukocytoclastic Vasculitis
title_full_unstemmed Apixaban as a Rare Cause of Leukocytoclastic Vasculitis
title_short Apixaban as a Rare Cause of Leukocytoclastic Vasculitis
title_sort apixaban as a rare cause of leukocytoclastic vasculitis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063214/
https://www.ncbi.nlm.nih.gov/pubmed/32181045
http://dx.doi.org/10.1155/2020/7234069
work_keys_str_mv AT spearsjenna apixabanasararecauseofleukocytoclasticvasculitis
AT chetritdavidalexandre apixabanasararecauseofleukocytoclasticvasculitis
AT mantheysina apixabanasararecauseofleukocytoclasticvasculitis
AT leechristopher apixabanasararecauseofleukocytoclasticvasculitis
AT alsaieghyousif apixabanasararecauseofleukocytoclasticvasculitis